| 481/710 | US=4 / Câncer Pulido JZ. Melanoma. In: Guimarães JLM, Rosa DD. Rotinas em oncologia. Porto Alegre: Artmed, 2008. p. 428-37. ISBN 85-3631168-5. MELANOMA. DIAGNOSTICO; MELANOMA. PATOLOGIA; MELANOMA. ESTADIAMENTO; MELANOMA. FATORES DE RISCO; MELANOMA. PROGNOSTICO; MELANOMA. TRATAMENTO |
| 482/710 | Câncer Campanholi LL, Duprat Neto JP, Fregnani JHTG. Analysis of physical therapy in patients who had radical lymphadenectomy for cutaneous melanoma. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.1, p. 12-5, 2012. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2012;32(1)p.12-5.pdf |
| 483/710 | US=42 / Gastro Carlson C, Greenhalf W, Brentnall TA. Screening of hereditary pancreatic cancer families. In: Beger H, Warshaw A, Büchler M, Kozarek RA, Lerch MM, Neoptolemos JP, Shiratori K, Whitcomb DC, Rau BM. The pancreas: an integrated textbook of basic science, medicine, and surgery. 2nd ed. Massachuetts: Blackwell Scientific Publications, 2008. p. 636-42. ISBN 978-1-4051-4664-7. CANCER DE PANCREAS; RASTREIO DE CANCRO HEREDITARIO; FAMILIAS PANCREATICAS; PANCREATITE HEREDITARIA; SINDROMES DE CANCRO DO COLON SEM POLIPOSE; SINDROMES DE CANCRO DO COLON COM POLIPOSE; MELANOMA FAMILIAR TOUPEIRA ATIPICA MULTIPLA |
| 484/710 | US=437 / Tese/FAP Benevides CFL. Avaliação do perfil de expressão de genes modulados por TNF e melfalano em culturas mistas de células endoteliais, células de melanoma e macrófagos. [Evaluation of the expression profile of genes modulated by TNF and melphalan in mixed cultures of endothelial cells, melanoma cells and macrophages]. São Paulo, 2012. 159 p. Tese(Doutorado)-Fundação Antonio Prudente. Disponível em: http://accamargo.phlnet.com.br/Doutorado/2012/CFBenevides/CFBenevides.pdf |
| 485/710 | US=3 / Ortopedia Morgan HD. Melanoma of the foot. In: Conrad III EU. Orthopaedic oncology: diagnosis and treatment. New York: Thieme, 2009. p. 275-8. ISBN 978-1-58890-523-9. |
| 486/710 | US=44 / Gastro McArdle C. Rare cancers. In: Jankowski J, Sampliner R, Kerr D, Fong Y. Gastrointestinal oncology: a critical multidisciplinary team approach. Massachuetts: Blackwell Scientific Publications, 2008. p. 374-407. ISBN 978-1-4051-2783-7. CARCINOIDE GASTROINTESTINAL; MELANOMA ANORRETAL; CANCER DO CANAL ANAL; NEOPLASIAS APENDICULARES; MESOTELIOMA PERITONEAL DIFUSO |
| 487/710 | US=49-D / Câncer Rubin H. Contact interactions between cells that suppress neoplastic development: can they also explain metastatic dormancy?. In: Woude GFV, Klein G. Advances in cancer research. v.100. Amsterdam: Elsevier, 2008. p. 159-202. ISBN 978-0-12-374358-9. CANCER; DESENVOLVIMENTO NEOPLASICO; INTERACAO CELULAR; FIBROBLASTOS; CELULAS EPITELIAIS; SUPRESSAO DE TRANSFORMACAO; MEMBRANA PLASMATICA; CRESCIMENTO TUMORAL; SUPRESSAO DE TECIDO MESENQUIMAL; PROLIFERACAO EPITELIAL NEOPLASICO; MELANOMA; DORMENCIA METASTATICA |
| 488/710 | US=06 / Câncer Rubin P, Hansen JT. Skin melanoma. In: ___. TNM staging atlas. Philadelphia: J.B. Lippincott Company, 2008. p. 453-9. ISBN 978-0-7817-6021-8. |
| 489/710 | US=65 / Biol/Mol Lah TT, Obermajer N, Alonso MBD, Kos J. Cysteine cathepsins and cystatins as cancer biomarkers. In: Edwards D, Hoyer-Hansen G, Blasi F, Sloane BF. The cancer degradome: proteases and cancer biology. New York: Spriger, 2008. p. 587-625. ISBN 978-0-387-69056-8. CATEPSINAS; CISTEINA; CISTATINAS; BIOMARCADORES DE CANCER; PEPTIDASES; PESQUISA CLINICA; CARCINOMA DE MAMA; CARCINOMA DE PROSTATA; CARCINOMA DO COLO DO UTERO; CARCINOMA DE OVARIO; CARCINOMA DE PULMAO; CARCINOMA DE COLON; CARCINOMA DE CABECA E PESCOCO; CARCINOMA DA BEXIGA; CARCINOMA DE PANCREAS; CANCER DE FIGADO; CARCINOMA HEPATOCELULAR; MELANOMA; MENINGIOMA; GLIOMA |
| 490/710 | US=67 / Biol/Mol Gupta A, Kirkwood JM. Melanoma. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 343-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. MELANOMA; PATOGENESE MOLECULAR; TERAPIA ALVO; INTERFERON; STAT; ANTISENSE BC12; BRAF; APOPTOSE; CICLO CELULAR |
| 491/710 | US=67 / Biol/Mol Perales MA, Wolchok JD, Kaufman HL. Vaccines as targeted cancer therapy. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 447-69. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. |
| 492/710 | US=67 / Biol/Mol Koon HB, Atkins MB. Cytokine-based therapy for cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 471-507. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER. TERAPIA; CITOQUINA; INTERFERON; INTERLEUCINA; IMUNOTERAPIA; RESISTENCIA; LEUCEMIA DE CELULAS PILOSAS; LEUCEMIA MIELOIDE CRONICA; LINFOMA NAO-HODGKIN; MELANOMA; CARCINOMA DE CELULAS RENAIS; SARCOMA DE KAPOSI |
| 493/710 | US=69 / Câncer Davies M, Patel S, Kim KB. Targeted therapy in melanoma. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 183-211. ISBN 978-1-60327-423-4. TERAPIA-ALVO EM PACIENTES COM MELANOMA; MELANOMA; TRANSDUCAO DE SINAL; QUINASE DO RECEPTOR; B-RAF; N-RAS; PTEN; MAP QUINASE; NFKB; ANTIOGENESIS; IMMUNOTARGETING |
| 494/710 | US=70 / Biol/Mol Bunz F. Genetic alternations in common cancers. In: ___. Principles of cancer genetics. New York: Springer, 2008. p. 227-57. ISBN 978-1-4020-6783-9. CANCER; ALTERACOES GENETICAS; GENES CANCERIGENOS; CANCER. INCIDENCIA; CANCER DE PULMAO; CANCER DE PROSTATA; CANCER DE MAMA; CANCER DE ENDOMETRIO; LINFOMA; CANCER DE BEXIGA; MELANOMA; CANCER DE OVARIO; CANCER DE RIM; LEUCEMIA; CANCER DE PANCREAS; CANCER DA CAVIDADE ORAL; CANCER DE FARINGE; CANCER DO COLO UTERINO; CANCER DE TIREOIDE; CANCER DE STOMACH; CANCER DO CEREBRO; CANCER DE FIGADO |
| 495/710 | US=8 / Dermatologia Kripke ML, Ananthaswamy HN. Carcinogenesis: ultraviolet radiation. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 371-7. ISBN 978-0-07138076-0. CARCINOGENESE; RADIACAO ULTRAVIOLETA; GENETICA; MECANISMOS MOLECULARES; MELANOMA |
| 496/710 | US=8 / Dermatologia Langley RG, Barnhill RL, Mihm MC Jr, Fitzpatrick TB, Sober AJ. Neoplasms: cutaneous melanoma. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 917-47. ISBN 978-0-07138076-0. NEOPLASIAS CUTANEAS; MELANOMA; MELANOMA. EPIDEMIOLOGIA; MELANOMA. FATORES DE RISCO; TUMORIGENESE; GRAVIDEZ; CRIANCA; ADOLESCENTE; MELANOMA RECORRENTE; MELANOMA METASTATICO; MELANOMA. DIAGNOSTICO; MELANOMA. TRATAMENTO |
| 497/710 | US=8 / Dermatologia Blauvelt A. Mucocutaneous manifestations of the non-HIV-infected immunosuppressed host. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1152-64. ISBN 978-0-07138076-0. MANIFESTACOES MUCOCUTANEAS; IMUNOSSUPRIMIDO NAO INFECTADO PELO HIV; CANDIDIASE; ASPERGILOSE; MUCORMICOSE; FUSARIOSE; TRICOSPORONOSE; CRIPTOCOCOSE; HISTOPLASMOSE; COCCIDIOIDOMICOSE; DERMATOFITOSE; HERPES VIRUS; PAPILOMAVIRUS HUMANO (HPV); PSEUDOMONAS; NOCARDIOSE; INFECCAO MICOBACTERIANA; ANGIOMATOSE BACILAR; STAPHYLOCOCCUS; STREPTOCOCCUS; INFECCAO NECROTIZANTE DOS TECIDOS MOLES; CANCER DE PELE NAO MELANOMA; SARCOMA DE KAPOSI |
| 498/710 | US=84-A / Biol/Mol Hsu FJ, Teicher BA, McPherson JM. Development of inhibitors of transforming growth factor-B signaling for therapy: rationale for anti-TGF-B antibody therapy in oncology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 757-74. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. FACTOR DE CRESCIMENTO TRANSFORMANTE-B; IMUNOSSUPRESSAO; METASTASE OSSEA; CARCINOMA DE CELULAS RENAIS; MELANOMA; CANCER DE MAMA; HORMONAL DO CANCER DA PROSTATA REFRATARIOS; CANCER DE PANCREAS; MIELOMA MULTIPLO; LINFOMA DE NAO-HOGGKIN; BIOMARCADORES |
| 499/710 | US=86 / Biol/Mol Hersey P, Zhang XD, Mhaidat N. Overcoming resistance to apoptosis in cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 105-26. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RESISTENCIA A APOPTOSE; ONCOGENE; MELANOMA; FAMILIA BCL-2 |
| 500/710 | US=220 / Mono/Enfermagem Alves DB. Melanoma e bioquimioterapia: uma revisão de literatura. São Paulo, 2012. 48 p. -[Monografia de Conclusão do Curso de Pós Graduação Lato Sensu Enfermagem Oncológica Fundação Antonio Prudente]. BIOQUIMIOTERAPIA; MELANOMA; QUIMIOTERAPIA; IMUNOTERAPIA; ANTINEOPLASICOS. USO TERAPEUTICO; TOXICIDADE; CUIDADOS DE ENFERMAGEM |
